paclitaxel has been researched along with Myocardial Ischemia in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.50) | 18.2507 |
| 2000's | 27 (67.50) | 29.6817 |
| 2010's | 11 (27.50) | 24.3611 |
| 2020's | 1 (2.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cattaneo, M; Conen, D; Coslovsky, M; Eberli, F; Engstrøm, T; Fahrni, G; Farah, A; Galatius, S; Jeger, RV; Kaiser, C; Mangner, N; Möbius-Winkler, S; Mueller, C; Pfister, O; Pfisterer, M; Rickenbacher, P; Schuler, G; Twerenbold, R | 1 |
| Kikuta, K; Kimura, K; Koide, S; Matsui, K; Matsumura, T; Nakao, K; Ogawa, H; Oka, H; Oshima, S; Sakamoto, T; Shimomura, H; Yamamoto, N | 1 |
| Wang, D; Wang, X; Xing, W; Zhu, H | 1 |
| Baim, DS; Caputo, R; Colombo, A; Dawkins, K; Ellis, SG; Friedman, MI; Grube, E; Maloney, T; Martin, JL; Stone, GW | 1 |
| Bligaard, N; Galløe, AM; Hansen, PR | 1 |
| Fujimaki, T; Fukuda, S; Hibino, T; Kato, K; Mori, T; Watanabe, K | 1 |
| Airaksinen, KE; Annala, AP; Karjalainen, PP; Vahlberg, T; Ylitalo, A | 1 |
| Byrne, RA; Dibra, A; Eberle, S; Iijima, R; Kastrati, A; Mehilli, J; Ndrepepa, G; Schömig, A | 1 |
| Beijk, MA; Claessen, BE; Henriques, JP; Legrand, V; Manari, A; Miquel-Hebert, K; Piek, JJ; Ruzyllo, W; Serruys, PW; Suttorp, MJ; Tijssen, JG; Varenne, O; Veldhof, S | 1 |
| Chen, YH; Li, J; Liang, D; Liu, Y; Peng, L; Xiao, J; Zhang, H; Zhao, H; Zhou, Z | 1 |
| Mizuno, K; Murakami, D; Okamatsu, K; Seino, Y; Takano, M; Yamamoto, M | 1 |
| Abdramanov, KA; Batyraliev, TA; Belenkov, IuN; Fettser, DV; Niyazova-Karben, ZA; Preobrazhenskiĭ, DV; Sidorenko, BA | 1 |
| Applegate, RJ; Cao, S; Hermiller, JB; Lansky, AJ; Nikolsky, E; Sanz, M; Sood, P; Stone, GW; Sudhir, K; Yaqub, M | 1 |
| Aizawa, T; Kadotani, M; Kamiya, H; Kashima, Y; Kawaguchi, R; Kawajiri, K; Kawashima, N; Muto, M; Nakatsu, Y; Nasu, K; Ogawa, T; Oikawa, Y; Okamura, A; Ota, H; Ozaki, T; Suzuki, M; Suzuki, T; Takeda, Y; Tohara, S; Uchida, Y; Usui, S; Yamaki, M; Yamashita, J; Yoshikawa, R | 1 |
| Cook, S; Eberli, FR; Eshtehardi, P; Jüni, P; Kalesan, B; Lüscher, T; Meier, B; Moschovitis, A; Räber, L; Seiler, C; Togni, M; Vogel, R; Wenaweser, P; Windecker, S | 1 |
| Miquel-Hebert, K; Onuma, Y; Serruys, PW | 1 |
| Allen, KB; Dzau, VJ; Griffin, E; Kleiman, NS; Patel, NC; Simons, M; Ylä-Herttuala, S | 1 |
| Angelini, GD; Bryan, AJ; Murphy, GJ | 1 |
| Ellis, SG; Kimmelstiel, C; Kosinski, E; Leon, MB; McGarry, TF; Mehran, R; Mishkel, GJ; Nikolsky, E; Russell, ME; Stone, GW | 1 |
| de Jaegere, PP; McFadden, EP; Ong, AT; Regar, E; Serruys, PW; van Domburg, RT | 1 |
| Ferraro, A; Indolfi, C; Mongiardo, A; Spaccarotella, C; Torella, D | 1 |
| Chang, M; Dangas, G; Ellis, SG; Kao, J; Laufer, N; Mehran, R; Russell, ME; Stone, GW; Tannenbaum, MA; Teirstein, PS; Watkins, M | 1 |
| Curzen, N; Hatrick, R; Teece, S | 1 |
| Bewig, B; Keussen, C; Lins, M; Schrader, C; von Freier, A | 1 |
| Benassi, A; Ewing, LG; Gioia, G; Levite, HA; Matthai, W; Rana, H | 1 |
| Holmes, DR | 1 |
| Gevorkian, N; Kent, KM; Okabe, T; Pichard, AD; Pinto Slottow, TL; Roy, P; Satler, LL; Smith, K; Steinberg, DH; Suddath, WO; Torguson, R; Waksman, R; Xue, Z | 1 |
| Aubry, P; Benamer, H; Ducrocq, G; Feldman, LJ; Himbert, D; Juliard, JM; Majdoub, MA; Sauguet, A; Steg, PG; Tchetche, D | 1 |
| Abbate, R; Antoniucci, D; Buonamici, P; Gensini, GF; Gori, AM; Marcucci, R; Migliorini, A; Moschi, G; Paniccia, R; Santini, A | 1 |
| Thomas, M | 1 |
| Benassi, A; Dralle, J; Gillin, K; Gioia, G; Gioia, MF; Matthai, W; White, J | 1 |
| Benoît, A; Berger, A; Goy, JJ; Seydoux, C; Siegenthaler, M; Stauffer, JC | 1 |
| Butman, SM | 1 |
| Abizaid, A; Cano, M; Centemero, M; Chaves, A; Costa, R; de Ribamar Costa, J; Feres, F; Maldonado, G; Mattos, LA; Moreira, AC; Quizhpe, AR; Sousa, AM; Sousa, JE; Staico, R; Tanajura, LF | 1 |
| Bucciarelli-Ducci, C; Colantonio, R; Fedele, F; Mancone, M; Sangiorgi, GM; Sardella, G | 1 |
| De Felice, F; Dibra, A; Fiorilli, R; Menichelli, M; Musto, C; Nazzaro, MS; Parma, A; Pucci, E; Violini, R | 1 |
| Austin, D; Oldroyd, KG; Pell, JP | 1 |
| Kaneda, H | 1 |
| Berkman, A; Mardelli, TJ; Soe, MS | 1 |
| Regar, E; Serruys, PW; Sianos, G | 1 |
7 review(s) available for paclitaxel and Myocardial Ischemia
| Article | Year |
|---|---|
Evolving revascularization approaches for myocardial ischemia.
Topics: Angiogenesis Inducing Agents; Angioplasty, Balloon, Coronary; Animals; Antineoplastic Agents, Phytogenic; Coronary Artery Bypass; DNA-Binding Proteins; Drug Delivery Systems; Fibroblast Growth Factors; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Laser Therapy; Myocardial Ischemia; Myocardial Revascularization; Nuclear Proteins; Paclitaxel; Stents; Transcription Factors; Vascular Endothelial Growth Factor A | 2003 |
Hybrid coronary revascularization in the era of drug-eluting stents.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cohort Studies; Combined Modality Therapy; Coronary Artery Bypass, Off-Pump; Coronary Restenosis; Disease-Free Survival; Drug Implants; Evaluation Studies as Topic; Female; Hospital Mortality; Humans; Internal Mammary-Coronary Artery Anastomosis; Length of Stay; Male; Middle Aged; Minimally Invasive Surgical Procedures; Multicenter Studies as Topic; Myocardial Ischemia; Paclitaxel; Prospective Studies; Randomized Controlled Trials as Topic; Reoperation; Retrospective Studies; Sirolimus; Stents; Treatment Outcome | 2004 |
The present and future of drug-eluting stents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Restenosis; Humans; Immunosuppressive Agents; Myocardial Ischemia; Paclitaxel; Prosthesis Design; Sirolimus; Stents | 2005 |
Incidence of late stent thrombosis with bare-metal, sirolimus, and paclitaxel stents.
Topics: Agnosia; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coronary Restenosis; Drug-Eluting Stents; Global Health; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Incidence; Metals; Myocardial Ischemia; Paclitaxel; Prosthesis Failure; Sirolimus | 2007 |
Drug-eluting stents: a review of current evidence on clinical effectiveness and late complications.
Topics: Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Myocardial Ischemia; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Treatment Outcome; Tubulin Modulators | 2008 |
Case report: paclitaxel-induced myocardial ischemia.
Topics: Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Female; Humans; Myocardial Ischemia; Neoplasm Metastasis; Paclitaxel | 1996 |
Stent development and local drug delivery.
Topics: Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Antineoplastic Agents; Biodegradation, Environmental; Coronary Restenosis; Dactinomycin; Drug Delivery Systems; Equipment Design; Humans; Myocardial Ischemia; Paclitaxel; Protein Synthesis Inhibitors; Sirolimus; Stents | 2001 |
13 trial(s) available for paclitaxel and Myocardial Ischemia
| Article | Year |
|---|---|
Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial.
Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Artery Bypass; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Long Term Adverse Effects; Male; Myocardial Ischemia; Paclitaxel; Percutaneous Coronary Intervention; Reoperation; Saphenous Vein; Stents; Treatment Outcome; Vascular Grafting | 2020 |
Rationale, design and baseline characteristics of a study to evaluate effects of candesartan on cardiovascular events after drug-eluting stent implantation in patients with ischemic heart disease.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Clinical Protocols; Combined Modality Therapy; Drug Discovery; Drug-Eluting Stents; Female; Humans; Japan; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Sirolimus; Tetrazoles | 2013 |
Frequency of coronary artery bypass grafting following implantation of a paclitaxel-eluting or a bare-metal stent into a single coronary artery.
Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Prognosis; Reoperation; Stents | 2009 |
[SORT OUT II--a randomized study of drug-eluting coronary stents--secondary publication].
Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Sirolimus; Treatment Outcome | 2009 |
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; India; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; New Zealand; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2009 |
Comparative angioscopic evaluation of neointimal coverage and thrombus between TAXUS-Express and TAXUS-Liberté stents: is the stent platform type associated with the vascular response?
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angioscopy; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Neointima; Paclitaxel | 2010 |
Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.
Topics: Age Factors; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Laser-Assisted; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Incidence; Longitudinal Studies; Male; Myocardial Ischemia; Paclitaxel; Risk Factors; Sirolimus; Treatment Outcome | 2011 |
A randomized comparison of sirolimus- vs. paclitaxel-eluting stents for treatment of bifurcation lesions by single stent and kissing balloon: results of the SINGLE KISS trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cross-Over Studies; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Sirolimus; Treatment Outcome | 2013 |
Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation.
Topics: Aged; Blood Vessel Prosthesis; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Incidental Findings; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Prospective Studies; Prosthesis Failure; Single-Blind Method; Sirolimus; Treatment Outcome; Tubulin Modulators; Ultrasonography, Interventional | 2012 |
Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial.
Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Single-Blind Method; Sirolimus; Treatment Outcome | 2013 |
Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).
Topics: Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Body Mass Index; Coronary Angiography; Coronary Disease; Coronary Restenosis; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Myocardial Ischemia; Obesity; Paclitaxel; Polymers; Proportional Hazards Models; Risk Factors; Stents | 2005 |
Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).
Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Creatine Kinase; Creatine Kinase, MB Form; Double-Blind Method; Drug Interactions; Eptifibatide; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Isoenzymes; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Paclitaxel; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Treatment Outcome; Tyrosine | 2005 |
Three-year follow-up of the first prospective randomized comparison between paclitaxel and sirolimus stents: the TAXi-LATE trial.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Prospective Studies; Prosthesis Design; Research Design; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2007 |
20 other study(ies) available for paclitaxel and Myocardial Ischemia
| Article | Year |
|---|---|
Taxol stabilizes gap junctions and reduces ischemic ventricular arrhythmias in rats in vivo.
Topics: Action Potentials; Animals; Antineoplastic Agents, Phytogenic; Arrhythmias, Cardiac; Connexin 43; Disease Models, Animal; Electrocardiography; Gap Junctions; Gene Expression Regulation; Myocardial Ischemia; Paclitaxel; Protein Multimerization; Protein Transport; Rats; Tubulin | 2015 |
Acute interstitial pneumonitis after implantation of paclitaxel-eluting stents: a report of two fatal cases.
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Fatal Outcome; Humans; Lung Diseases, Interstitial; Male; Myocardial Ischemia; Paclitaxel | 2011 |
Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population.
Topics: Alloys; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Ischemia; Myocardial Revascularization; Paclitaxel; Patient Selection; Prospective Studies; Prosthesis Design; Registries; Secondary Prevention; Time Factors; Titanium; Treatment Outcome | 2010 |
Distribution of angiographic measures of restenosis after drug-eluting stent implantation.
Topics: Aged; Blood Vessel Prosthesis; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Myocardial Ischemia; Paclitaxel; Prospective Studies; Prosthesis Failure; Sirolimus; Treatment Outcome; Tubulin Modulators | 2009 |
Taxol, a microtubule stabilizer, improves cardiac contractile function during ischemia in vitro.
Topics: Animals; Calcium Signaling; Cells, Cultured; Electron Transport Chain Complex Proteins; Heart Failure; Heart Ventricles; Homeostasis; In Vitro Techniques; Male; Microtubules; Mitochondria, Heart; Myocardial Contraction; Myocardial Ischemia; Myocytes, Cardiac; Paclitaxel; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Time Factors; Tubulin Modulators; Ventricular Dysfunction, Left | 2010 |
[Inhospital and 12-months results of percutaneous coronary interventions with implantation of Paclitaxel eluting stents in patients with long de novo coronary artery lesions].
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug Delivery Systems; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Plaque, Atherosclerotic; Treatment Outcome; Tubulin Modulators | 2010 |
Late angiographic stent thrombosis (LAST) events with drug-eluting stents.
Topics: Adult; Aged; Blood Vessel Prosthesis Implantation; Coronary Thrombosis; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Radiography; Sirolimus; Stents; Time Factors | 2005 |
Seeing transient regional myocardial ischaemia through new eyes.
Topics: Aged; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Body Surface Potential Mapping; Coated Materials, Biocompatible; Coronary Stenosis; Humans; Image Processing, Computer-Assisted; Male; Myocardial Ischemia; Myocardial Reperfusion; Paclitaxel; Stents | 2005 |
Symptoms and signs of an acute myocardial ischemia caused by chemotherapy with Paclitaxel (Taxol) in a patient with metastatic ovarian carcinoma.
Topics: Acute Disease; Angina Pectoris; Anticoagulants; Antineoplastic Agents, Phytogenic; Bradycardia; Carcinoma; Electrocardiography; Female; Follow-Up Studies; Heparin; Humans; Middle Aged; Myocardial Ischemia; Nausea; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Treatment Outcome | 2005 |
Improved survival with drug-eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction.
Topics: Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; Cardiomyopathies; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Female; Follow-Up Studies; Heart Failure; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Paclitaxel; Prosthesis Design; Research Design; Severity of Illness Index; Sirolimus; Stents; Stroke Volume; Survival Rate; Treatment Outcome; United States; Ventricular Dysfunction, Left | 2006 |
Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Research Design; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2007 |
[Treatment of intrastent restenosis by drug eluting stents: experience from one cardiology centre].
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Stents; Surface Properties; Ticlopidine; Treatment Outcome | 2007 |
Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.
Topics: Adult; Antineoplastic Agents, Phytogenic; Blood Platelets; Clopidogrel; Comorbidity; Female; Humans; Immunosuppressive Agents; Male; Multivariate Analysis; Myocardial Ischemia; Paclitaxel; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Sirolimus; Stents; Thrombosis; Ticlopidine | 2007 |
Revascularization for ischemic LV dysfunction: stents or surgery?
Topics: Angioplasty, Balloon, Coronary; Cardiomyopathies; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Bypass; Humans; Myocardial Ischemia; Paclitaxel; Patient Selection; Prosthesis Design; Radiography; Severity of Illness Index; Sirolimus; Stents; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2007 |
Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiomyopathies; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Bypass; Female; Follow-Up Studies; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Prosthesis Design; Research Design; Retrospective Studies; Severity of Illness Index; Sirolimus; Stents; Time Factors; Treatment Outcome; United States; Ventricular Dysfunction, Left | 2007 |
What kind of stent for you today and how would you like it prepared?
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Humans; Myocardial Ischemia; Paclitaxel; Patient Selection; Prosthesis Design; Risk Assessment; Severity of Illness Index; Sirolimus; Stents; Thrombosis; Treatment Outcome | 2007 |
Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Coronary Vessels; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Sirolimus; Stents | 2007 |
Very late paclitaxel-eluting stent thrombosis despite 21 months of clopidogrel treatment after percutaneous coronary intervention.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Humans; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prosthesis Design; Stents; Syndrome; Ticlopidine; Time Factors; Treatment Outcome | 2007 |
Clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chronic Disease; Coronary Angiography; Coronary Occlusion; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Prognosis; Proportional Hazards Models; Retrospective Studies; Sirolimus; Stents; Treatment Outcome | 2009 |
Study power in the SORT OUT II trial.
Topics: Data Interpretation, Statistical; Drug-Eluting Stents; Humans; Myocardial Ischemia; Paclitaxel; Research Design; Sirolimus; Treatment Outcome | 2008 |